Theodore Karrison to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Theodore Karrison has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.144
-
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products. Leuk Lymphoma. 2008 Mar; 49(3):531-7.
Score: 0.072
-
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia. Invest New Drugs. 2008 Jun; 26(3):233-9.
Score: 0.072